Inherited Metabolic Disorders: Deletion/Duplication Panel
Condition Description
Inherited metabolic disorders refer to diseases caused by defects in
genes that are involved in the body’s metabolism. These usually involve
the production, conversion, or use of energy. Traditionally, inherited
metabolic conditions were broadly classified as disorders of
carbohydrate metabolism, amino acid metabolism, organic acid metabolism,
or lysosomal storage diseases. This test analyses genes involved in
complex metabolic processes in the body including but not limited to the
above four categories.
Reference:
Reference:
- OMIM.
Genes (100)
ACAD9, ACADL, ACADM, ACADS, ACADVL, ACSF3, AGA, AGL, ARSA, ARSB, ASL, ASS1, ATPAF2, AUH, BCKDHA, BCKDHB, CD320, CLN3, CLN5, CLN6, CLN8, CPS1, CPT1A, CPT2, DBT, DLD, ENO3, ETFA, ETFB, ETFDH, G6PC, GAA, GALC, GALNS, GBE1, GLA, GLB1, GM2A, GNPTAB, GYS1, GYS2, HADHA, HADHB, HGSNAT, HLCS, HMGCL, HMGCS2, HYAL1, IDS, IDUA, IVD, LIPA, LMBRD1, LPIN1, MAN2B1, MANBA, MCCC1, MCCC2, MCEE, MCOLN1, MFSD8, MLYCD, MMAA, MMAB, MMACHC, MMADHC, MTR, MTRR, MUT, NAGA, NAGLU, NAGS, NEU1, NPC1, NPC2, OPA3, OTC, PC, PCCA, PCCB, PFKM, POLG, PPT1, PYGL, PYGM, SERAC1, SGSH, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC25A20, SLC37A4, SLC7A7, SMPD1, SUCLG1, SUMF1, TAZ, TMEM70, TPP1
Your search may have returned a result for a gene alias. Click here for a full list of genes and their aliases.
Indications
This test is indicated for:
- Confirmation of a clinical diagnosis of inherited metabolic disorders.
Methodology
Deletion/Duplication Analysis: DNA
isolated from peripheral blood is hybridized to a gene-targeted CGH
array to detect deletions and duplications. The targeted CGH array has
overlapping probes that cover the entire genomic region.
Please note that a "backbone" of probes across the entire genome are included on the array for analytical and quality control purposes. Rarely, off-target copy number variants causative of disease may be identified that may or may not be related to the patient's phenotype. Only known pathogenic off-target copy number variants will be reported. Off-target copy number variants of unknown clinical significance will not be reported.
Please note that a "backbone" of probes across the entire genome are included on the array for analytical and quality control purposes. Rarely, off-target copy number variants causative of disease may be identified that may or may not be related to the patient's phenotype. Only known pathogenic off-target copy number variants will be reported. Off-target copy number variants of unknown clinical significance will not be reported.
Detection
Deletion/Duplication Analysis: Detection is limited to
duplications and deletions. The CGH array will not detect point or
intronic mutations. Results of molecular analysis must be interpreted in
the context of the patient's clinical and/or biochemical phenotype.
Specimen Requirements
When sample fails to meet the acceptable criteria, please call 470.378.2200 and ask to speak with a laboratory genetic counselor (eglgc@egl-eurofins.com).
Submit only 1 of the following specimen types
Type: Whole Blood
Specimen Requirements:
In EDTA (purple top) tube:Infants (<2 years): 2-3 ml
Children (>2 years): 3-5 ml
Older Children & Adults: 5-10 ml
Specimen Collection and Shipping: Ship sample at room temperature with overnight delivery.
Type: Isolated DNA
Specimen Requirements:
In microtainer: 10 ugIsolation using the QiagenTM Puregene kit for DNA extraction is recommended.
Specimen Collection and Shipping: Refrigerate until time of shipment in 100 ng/ul of TE buffer. Ship sample at room temperature with overnight delivery.
Related Tests
- Inherited Metabolic Disorders: Sequencing Panel